infectagentscancer.com/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Infectious Agents and Cancer
unofficial impact factor 3.17
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Infectious Agents and Cancer

Submit a manuscript Register Sign up for article alerts Contact us Follow
BioMed Central
Support

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most viewed RSS
  • Archive
  • Supplements
  • Article collections

Infectious Agents and Cancer publishes selected collections of research articles, conference proceedings, reviews and reports as supplements, which are free to access online. All articles published in supplements are subject to peer review; meeting abstracts undergo review and selection by the conference. Find out more about publishing a supplement with BioMed Central.

Volume 4 Supplement 2

Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Meeting abstracts

11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Bethesda, MD, USA

6-7 October 2008

Publication of this supplement was made possible with support from the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health.

Additional Information | Conference website

Oral presentation   Open Access

Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers

R Modali, J Goedert, E Engels, LW Ayers, K Bhatia Infectious Agents and Cancer 2009, 4(Suppl 2):O1 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study

J Bohlius Infectious Agents and Cancer 2009, 4(Suppl 2):O2 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

M Bruyand, R Thiebaut, F Dabis, S Lawson-Ayayi, P Joly, AJ Sasco, P Mercie, JL Pellegrin, S Geffard, D Neau, P Morlat, G Chene, F Bonnet, the Goupe D'Epidemiologie Clinique Du Sida En Aquitaine (GECSA) Infectious Agents and Cancer 2009, 4(Suppl 2):O3 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

A population-based study of how children are exposed to saliva in Africa: implications for KSHV transmission

LM Butler, S Mzolo, A Mosam, JN Martin Infectious Agents and Cancer 2009, 4(Suppl 2):O4 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

HQ Nguyen, F Okuku, F Ssewankambo, AS Magaret, C Johnston, A Wald, A Kambugu, L Corey, J Orem, C Casper Infectious Agents and Cancer 2009, 4(Suppl 2):O5 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

GM Clifford, M Rickenbach, S Franceschi, the Swiss HIV Cohort Study Infectious Agents and Cancer 2009, 4(Suppl 2):O6 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers

A Bhatt, P Bhende, B Damania Infectious Agents and Cancer 2009, 4(Suppl 2):O7 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

High resolution profiling of DNA copy number and gene expression changes in AIDS-related lymphoma

KE Deffenbacher, Z Liu, J Iqbal, H Geng, K Fu, WC Chan Infectious Agents and Cancer 2009, 4(Suppl 2):O8 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab

K Dunleavy, RF Little, AS Wayne, N Grant, S Pittaluga, ES Jaffe, S Steinberg, R Yarchoan, J Carrasquillo, J Janik, WH Wilson Infectious Agents and Cancer 2009, 4(Suppl 2):O9 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Epidemiology of non-keratinocytic skin cancers among persons with AIDS in the United States

E Lanoy, GM Dores, MM Madeleine, JR Toro, JF Fraumeni, EA Engels Infectious Agents and Cancer 2009, 4(Suppl 2):O10 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

HIV induces the expression of activation-induced cytidine deaminase (AICDA) in B cells through a direct interaction between virion-associated CD40L and CD40

M Epeldegui, S Kitchen, J De La Cruz, J Zack, O Martinez-Maza Infectious Agents and Cancer 2009, 4(Suppl 2):O11 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses

P Gasperini, G Tosato Infectious Agents and Cancer 2009, 4(Suppl 2):O12 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

An invasion mechanism for human papillomavirus related cancers: HPV 16 E6 degrades PTPN13 allowing enhanced map kinase signaling

AC Hoover, GL Strand, PN Nowicki, ME Anderson, AJ Klingelhutz, AD Bossler, JH Lee Infectious Agents and Cancer 2009, 4(Suppl 2):O13 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL)

A Krishnan, J Zaia, J Alvarnas, N Kogut, J Cai, A Nademanee, J Palmer, N Tsai, SJ Forman Infectious Agents and Cancer 2009, 4(Suppl 2):O14 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study

E Lanoy, JP Spano, F Bonnet, F Boué, C Katlama, D Costagliola Infectious Agents and Cancer 2009, 4(Suppl 2):O15 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Cisplatin and radiation therapy induces an immunologic clearance of HPV-positive head and neck cancer

PW Nowicki, WC Spanos, DW Lee, ME Anderson, AJ Hoover, JH Lee Infectious Agents and Cancer 2009, 4(Suppl 2):O16 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation

JN Martin, M Laker, A Kambugu, D Janka, J Orem, A Mwaka, T Maurer, EK Mbidde Infectious Agents and Cancer 2009, 4(Suppl 2):O17 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Preliminary findings on cancer incidence in HIV-infected persons from six countries in Central and South America and the Caribbean

DR Masys, F Fang, I Ye, V Fink, E Gotuzzo, D Padgett, JW Pape, C Cortes, M Bacon, M Schechter Infectious Agents and Cancer 2009, 4(Suppl 2):O18 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Profiling of cellular and viral microRNAs in Kaposi sarcoma and viral-associated lymphoma

DP Dittmer, AJ O'Hara, L Wang, BJ Dezube, W Harrington, B Damania Infectious Agents and Cancer 2009, 4(Suppl 2):O19 (17 June 2009)

Full text | PDF

Oral presentation   Open Access

Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)

R Yarchoan, D O'Mahony, K Aleman, KM Wyvill, D Whitby, W Bernstein, S Pittaluga, ES Jaffe, G Tosato, DA Davis, SM Steinberg, RF Little Infectious Agents and Cancer 2009, 4(Suppl 2):O20 (17 June 2009)

Full text | PDF

View more

  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.